Schedule 13D ownership disclosure

Targanta Therapeutics Corp.

Security class unavailable · CUSIP: 87612C100

Event date: 2014-06-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,943,241
Percent of class
6.7100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001028348-14-000008
Form type
SC 13D/A
Filer
BROOKSIDE CAPITAL PARTNERS FUND LP
CIK
CIK 1028348
Filed
Jun 10, 2014
Reporting period
Jun 06, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub